{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T04:18:47Z","timestamp":1747196327646,"version":"3.40.5"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Objectives<\/jats:title>\n<jats:p>It is not known why only some hepatitis C virus (HCV) infected patients develop glomerulonephritis (GN). Therefore, we investigated the role of soluble complement regulators in the development of HCV associated GN.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Patients with HCV associated GN who were admitted to our nephrology unit between July 2016 and July 2018 were recruited to the study (group 1). Two other age and sex matched groups were studied as control groups: patients with HCV without GN (group 2) and healthy HCV negative volunteers (group 3). There were 26 participants in each of the three groups at the end of the recruitment period. An assay of serum fluid-phase complement regulators was performed using enzyme linked immunosorbent assay technique. Three complement single nucleotide polymorphisms (SNPs) were analyzed using real time polymerase chain reaction (Taqman; thermo fisher scientific): rs2230199 and rs1047286 for complement 3 (C3) and rs800292 for complement factor H (CFH).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Serum levels of complement 4 binding protein (C4BP) were significantly lower in group 1 (median 70 ng\/ml) than in groups 2 (median 88.8 ng\/ml) and 3 (median 82.8 ng\/ml) with p value of 0.007. The minor allele (allele A) of rs800292 for CFH was significantly higher in group 2 and group 3 (G 54% and A 46%) than in group 1 (G 73% and A 27%), p = 0.04.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Low C4BP levels are associated with GN in HCV infected patients. In addition, rs800292 SNP in CFH protects against GN in patients with HCV.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0276017","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T17:39:31Z","timestamp":1665682771000},"page":"e0276017","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of fluid-phase complement system regulation in the development of hepatitis C virus-associated glomerulonephritis"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7442-7902","authenticated-orcid":true,"given":"Sara T.","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa R.","family":"Abdelhamid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neveen","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahed","family":"Baddour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed G.","family":"Adam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,10,13]]},"reference":[{"key":"pone.0276017.ref001","unstructured":"WHO. Hepatitis C Fact sheet (164) [Accessed 2022 September 15] Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs164\/en\/"},{"key":"pone.0276017.ref002","first-page":"40"},{"key":"pone.0276017.ref003","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1053\/j.ajkd.2010.09.023","article-title":"HCV infection and the incidence of chronic kidney disease","volume":"57","author":"A Butt","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"pone.0276017.ref004","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/archinte.167.12.1271","article-title":"Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease","volume":"167","author":"JI Tsui","year":"2007","journal-title":"Arch Intern Med"},{"key":"pone.0276017.ref005","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMra1108178","article-title":"Membranoproliferative Glomerulonephritis A New Look at an Old Entity","volume":"366","author":"S Sanjeev","year":"2012","journal-title":"N Engl J Med"},{"key":"pone.0276017.ref006","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-133-8-200010170-00009","article-title":"Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States","volume":"133","author":"SH Mehta","year":"2000","journal-title":"Ann Intern Med"},{"key":"pone.0276017.ref007","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1001\/jama.1997.03550230045035","article-title":"Risk of end stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial","volume":"278","author":"FL Brancati","year":"1997","journal-title":"JAMA"},{"key":"pone.0276017.ref008","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s12072-015-9684-3","article-title":"Hepatitis C virus as a systemic disease: reaching beyond the liver","volume":"10","author":"K Gill","year":"2016","journal-title":"Hepatol Int"},{"key":"pone.0276017.ref009","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00041552-199903000-00009","article-title":"Glomerulonephritis associated with hepatitis C virus infection","volume":"8","author":"J Morales","year":"1999","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"pone.0276017.ref010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000045243","article-title":"Focal segmental glomerular sclerosis among patients infected with hepatitis C virus","volume":"81","author":"C Stehman-Breen","year":"1999","journal-title":"Nephron"},{"key":"pone.0276017.ref011","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1038\/ki.1994.471","article-title":"Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy","volume":"46","author":"RJ Johnson","year":"1994","journal-title":"Kidney Int"},{"key":"pone.0276017.ref012","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1681\/ASN.V101146","article-title":"Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients","volume":"10","author":"S Baid","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"pone.0276017.ref013","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1681\/ASN.V9122244","article-title":"Hepatitis C viral infectionis associated with fibrillary glomerulonephritis and immunotactoid glomerulopathy","volume":"9","author":"GS Markowitz","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"pone.0276017.ref014","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/clim.2001.5098","article-title":"Cryoprecipitate of patients with cryoglobulinemic glomerulo-nephritis contains molecules of the lectin complement pathway","volume":"101","author":"I Ohsawa","year":"2001","journal-title":"Clinical Immunology"},{"key":"pone.0276017.ref015","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins","volume":"9","author":"PF Zipfel","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"pone.0276017.ref016","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1681\/ASN.2010080795","article-title":"Allelic variants of complement genes associated with dense depositdisease","volume":"22","author":"MA Abrera-Abeleda","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"pone.0276017.ref017","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.1073\/pnas.1019338108","article-title":"Common polymorphisms in C3, factor B, and factor H collaborateto determine systemic complement activity and disease risk","volume":"108","author":"M Heurich","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0276017.ref018","first-page":"32","article-title":"Prescribing in liver disease","volume":"32","author":"A Sloss","year":"2009","journal-title":"AustPrescr"},{"issue":"2","key":"pone.0276017.ref019","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.transproceed.2016.02.023","article-title":"Comparison Between CKD-EPI Creatinine and MDRD Equations to Estimate Glomerular Filtration Rate in Kidney Transplant Patients","volume":"48","author":"CA Mombelli","year":"2016","journal-title":"Transplant Proc"},{"issue":"10","key":"pone.0276017.ref020","doi-asserted-by":"crossref","first-page":"836","DOI":"10.2169\/internalmedicine.37.836","article-title":"Glomerulonephritis in autopsy cases with hepatitis C virus infection","volume":"37","author":"Y Arase","year":"1998","journal-title":"Intern Med"},{"key":"pone.0276017.ref021","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/ki.2014.181","article-title":"Novel evidence on hepatitis C virus-associated glomerular disease","volume":"86","author":"F Fabrizi","year":"2014","journal-title":"Kidney Int"},{"key":"pone.0276017.ref022","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1128\/JVI.02449-10","article-title":"Transcriptional repression of C4 complement by hepatitis C virus proteins","volume":"85","author":"A Banerjee","year":"2011","journal-title":"J Virol"},{"key":"pone.0276017.ref023","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1128\/JVI.06577-11","article-title":"Hepatitis C virus proteins inhibit C3 complement production","volume":"86","author":"B Mazumdar","year":"2012","journal-title":"J Virol"},{"issue":"7","key":"pone.0276017.ref024","doi-asserted-by":"crossref","first-page":"e101422","DOI":"10.1371\/journal.pone.0101422","article-title":"Inhibition of C3 Convertase Activity by Hepatitis C Virus as an Additional Lesion in the Regulation of Complement Components.","volume":"9","author":"H Kim","year":"2014","journal-title":"PLoS One"},{"key":"pone.0276017.ref025","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1128\/JVI.00174-13","article-title":"Hepatitis C virus suppresses C9 complement synthesis and impairs membrane attack complex function","volume":"87","author":"H Kim","year":"2013","journal-title":"J Virol"},{"key":"pone.0276017.ref026","doi-asserted-by":"crossref","first-page":"26568","DOI":"10.1038\/srep26568","article-title":"A Novel Complotype Combination Associates with Age-Related Macular Degeneration and High Complement Activation Levels in vivo","volume":"6","author":"C Paun","year":"2016","journal-title":"Sci Rep"},{"key":"pone.0276017.ref027","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1084\/jem.20070301","article-title":"Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains","volume":"204","author":"MC Pickering","year":"2007","journal-title":"J Exp Med"},{"issue":"18","key":"pone.0276017.ref028","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1093\/hmg\/ddp289","article-title":"The disease-protective complement factor H allotypic variant Ile62 shows increased binding affinity for C3b and enhanced cofactor activity","volume":"18","author":"A Tortajada","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"84","key":"pone.0276017.ref029","first-page":"180","article-title":"Regulation of C1-inhibitor synthesis by interferons and other agents","author":"D Lappin","year":"1989","journal-title":"Behring Inst Mitt"},{"issue":"3","key":"pone.0276017.ref030","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1042\/bj2710767","article-title":"Interferon-induced transcriptional and post-transcriptional modulation of factor H and C4 binding-protein synthesis in human monocytes","volume":"271","author":"D Lappin","year":"1990","journal-title":"Biochem"},{"issue":"3","key":"pone.0276017.ref031","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1128\/iai.40.3.1011-1014.1983","article-title":"Steroids inhibit activation of the alternative-amplification pathway of complement","volume":"40","author":"BD Packard","year":"1983","journal-title":"Infect Immun"},{"issue":"5","key":"pone.0276017.ref032","first-page":"7459","article-title":"Hepatitis B virus inhibits the expression of complement C3 and C4, in vitro and in vivo","volume":"15","author":"C Zhu","year":"2018","journal-title":"Oncol Lett"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0276017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T17:40:05Z","timestamp":1665682805000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0276017"}},"subtitle":[],"editor":[{"given":"Hussein H.","family":"Aly","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,10,13]]},"references-count":32,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0276017","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2022,10,13]]}}}